Dan Ma
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 4
- Circular RNAs in diseases 3
- Epigenetics and DNA Methylation 2
-
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 4
- Co-authors
- Honggang Nie (1 shared paper)Changlin Zhai (1 shared paper)Kuikui Zhang (1 shared paper)Guang Yang (1 shared paper)Shuang Yang (1 shared paper)Bo Yu (1 shared paper)Kai Liu (1 shared paper)Yang Liu (1 shared paper)
- Journals
- Scientific Reports (1 paper)Bioscience Reports (1 paper)Cell Death and Disease (1 paper)FEBS Letters (1 paper)Acta Pharmacologica Sinica (1 paper)
- Partner nations
- ChinaFranceUnited States
In The Last Decade
Dan Ma
21 papers receiving 418 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 235
- Molecular Biology 269
- Complementary and Manual Therapy 8
- Orthodontics 11
- Periodontics 8
Countries citing papers authored by Dan Ma
This map shows the geographic impact of Dan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Ma more than expected).
Fields of papers citing papers by Dan Ma
This network shows the impact of papers produced by Dan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Ma. The network helps show where Dan Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 78 | |
| 2 | 2019 | 55 | |
| 3 | 2006 | 45 | |
| 4 | 2016 | 45 | |
| 5 | 2021 | 36 | |
| 6 | 2019 | 27 | |
| 7 | 2023 | 25 | |
| 8 | 2019 | 18 | |
| 9 | 2020 | 13 | |
| 10 | 2019 | 13 | |
| 11 | 2021 | 12 | |
| 12 | 2020 | 10 | |
| 13 | 2020 | 10 | |
| 14 | 2015 | 8 | |
| 15 | 2016 | 7 | |
| 16 | 2017 | 5 | |
| 17 | [Association between single nucleotide polymorphisms in -88 and -123 loci of MxA gene promoter region and HCV susceptibility and IFN-α efficacy]. | 2012 | 5 |
| 18 | [Effects of Rhubarbs from different regions on blood lipid and antioxidation of hyperlipidemia rats]. | 2015 | 5 |
| 19 | [Comparison of two treatment method for maxillary incisors intrusion]. | 2013 | 4 |
| 20 | 2011 | 1 |
About Dan Ma
Dan Ma is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Immunology and Genetics, having authored 22 papers that have together received 423 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers), Circular RNAs in diseases (3 papers), Mesenchymal stem cell research (2 papers), Epigenetics and DNA Methylation (2 papers), Oral microbiology and periodontitis research (2 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Cancer Research (235 citations), Molecular Biology (269 citations), Complementary and Manual Therapy (8 citations), Orthodontics (11 citations) and Periodontics (8 citations). Dan Ma has collaborated with scholars based in China, France and United States. Frequent co-authors include Honggang Nie, Changlin Zhai, Kuikui Zhang, Guang Yang, Shuang Yang, Bo Yu, Kai Liu, Yang Liu, Yang Liu and Guoyan Liu. Their work appears in journals such as Scientific Reports, Bioscience Reports, Cell Death and Disease, FEBS Letters and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.